APAC Needles Market

APAC Needles Market Size (2022 to 2027)

The size of the Needles Market in the Asia Pacific region was worth USD 1.65 billion in 2022. It is estimated to be growing at a CAGR of 8.1% to reach USD 2.61 billion by 2027.

Needles in healthcare and medicine are hallowed devices used to inject and administer medication. For example, surgical needles and syringes are widely used to inject medication or withdraw fluids such as blood and serum for various diagnostic purposes.

Factors such as blood donation drive, awareness on blood donations, increased occurrences of chronic diseases, need for surgeries in the emergence, and need for drug administration are expected to drive the APAC needles market. The rise in demand for aesthetics and cosmetic surgeries with increased beauty consciousness also increases the needle market demand in the APAC region. Increased diagnostic setups, laboratories, clinics, hospitals, and care centers raise the need for needles' availability. Stringent regulations and government awareness systems on early detection of diseases and their prevention through treatment increase the growth of the needle market in the Asia Pacific region.

The increase in the use of needles in blood screening or testing for various diseases such as diabetes, cancers, HIV infections for different complex surgeries is estimated to boost the APAC needles market growth. Various research and developmental activities by multiple companies, pharmaceuticals, and research laboratories are predicted to favor the growth rate of the market. Low costs associated with the purchase and high availability of needles are some other primary market drivers. 

Patient compliance is a significant drawback to the growth of the APAC needles market. For instance, specific treatment plans are always associated with repeated administration of drugs. In such cases, patients are triggered for pain. Hence needles are not suitable in terms of pain management systems. It is a significant drawback of the needles market in the Asia-Pacific region. The sterilization of needles, storage systems for these medical needles are harder. The sterilization equipment and setups are highly priced and are not affordable by every hospital management system. Support from the government end in this region for installing sterilizing and storage is also feeble, hampers the APAC needles market growth. 

This research report on the Asia Pacific Needles Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2027.

By Type: 

• Conventional Needles
• Bevel Needles
• Blunt Fill Needles
• Filter Needles
• Vented Needles
• Safety Needles
• Active Needles
• Passive Needles

By Product: 

• Suture Needles
• Blood Collection Needles
• Ophthalmic Needles
• Dental Needles
• Insufflation Needles
• Pen Needles
• Other Needles

By Delivery Mode: 

• Hypodermic Needles
• Intravenous Needles
• Intramuscular Needles
• Intraperitoneal Needles

By Material: 

• Stainless Steel Needles
• Plastic Needles
• Glass Needles
• PEEK Needles

By End User: 

• Hospitals & Clinics
• Diagnostic Centers
• Home Healthcare

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Regional Analysis:

Geographically, the Asia-Pacific needles market is predicted to be the third-largest regional market in the global needles market after North America and Europe. The major factors responsible for the growth of this market are the increasing number of chronic diseases, a rising number of cardiovascular diseases, the development in medical technology, and the increasing aging population. The only constraint the market faces is the high risk associated with drug delivery through needles. Additionally, factors such as growing demand for surgeries, chronic diseases like cancers, diabetes, cardiovascular stent procedures, Diagnosing HIV infections increase market size.

The Japanese needles market is expected to register the fastest growth rate in the APAC market due to the increasing chronic disease requiring surgeries. Indian owns the largest shares after Japan as the material cost for manufacturing needles is low.

The Indian needles market is estimated to account for a significant share in the APAC market during the forecast period. On the other end, the Chinese needles market is forecasted to be another lucrative region in the APAC market between 2022 to 2027.

Countries such as China, Australia, New Zealand, Thailand, and South Korea are expected to witness healthy growth rates during the forecast period.

KEY MARKET PLAYERS:

Some of the major companies leading the APAC needles market profiled in the report are Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, and Smiths Medical, Terumo Corporation, Smiths Medical, and Thermo Fisher Scientific.